News Navigating Startup Success: Polsky Launches the ‘Compass,’ a New Deep Tech Accelerator Program The Polsky Center for Entrepreneurship and Innovation recently launched the Compass – a first-of-its-kind deep tech accelerator program for early-stage startups and technologies. “Backed by a 25-year history of launching...
News Compass Teams Gain ‘Clarity of Focus,’ Investor-Ready Pitches, and a ‘Deep Network of Experts’ The Polsky Center for Entrepreneurship and Innovation’s recently-launched Compass accelerator program has concluded its second cohort, which featured four teams working on developing deep tech with applications in various industries. Designed...
Technology Oral Systemically-Bioavailable Butyrate For Treating Inflammatory Diseases Method to attach butyrate to amino acids, allowing it to bypass gut metabolism and enter the bloodstream, increasing its bioavailability and enabling effective treatment of inflammatory, immune, and neurological conditions…
News Polsky Supports 13 Teams in Spring Quarter I-Corps Cohort The Polsky Center ran its National Science Foundation (NSF)-supported I-Corps program virtually during the Spring quarter and accepted the largest number of teams of any cohort managed to-date. Polsky supported...
News Record $1.6 Million Awarded in the 25th Anniversary Finals of Chicago Booth’s New Venture Challenge; First-Place Winner Andes STR Lands More Than $660,000 The Polsky Center for Entrepreneurship and Innovation at the University if Chicago has announced a record-breaking investment of $1.6 million in the winners of the 2021 Edward L. Kaplan, ’71, New...
News Edward L. Kaplan, ’71, New Venture Challenge Investment Pool Swells to $1.73 Million After Additional Funding Rolls In; First-Place Winner Andes STR Gets $681,000 The record investment pool in the 25th annual Edward L. Kaplan, ’71, New Venture Challenge (NVC) jumped to $1.73 million this week after investors put additional money into the finalist...
Technology Engineered Flt3L Variants For Antigen Tolerance Induction Engineered recombinant fusion of the dendritic cell growth factor Flt3L to serum albumin to modulate the antigen-presenting compartment and bias it toward tolerance particularly against therapeutic proteins. The Unmet Need:…
Technology Novel Use of a Bet Bromodomain Protein Inhibitor (JQ1) for the Treatment of Sickle Cell Anemia and Thalassemia Embryonic and fetal hemoglobin have a higher affinity for oxygen than their adult counterpart, and as such, gene editing techniques to revert red blood cells to produce infant or fetal…
Technology Programmable Translational-Activating RNA Therapeutic Platform Technology Many human diseases arise from insufficient protein levels, often due to genetic mutations that result in haploinsufficiency or loss of protein function. Effectively treating these conditions necessitates therapeutic strategies capable…
News Subli, a peer-to-peer subletting marketplace, wins $25,000 at the 2020 College New Venture Challenge The Polsky Center for Entrepreneurship and Innovation at the University of Chicago is pleased to announce the winners of the 2020 College New Venture Challenge (CNVC). The CNVC is the College track of...
News 6 Chicago Booth Students Honored with 2024 Student Entrepreneurship Awards Chicago Booth School of Business recently recognized six outstanding MBA students who demonstrated leadership in entrepreneurship, venture capital, or private equity during their time at school. The annual Student Entrepreneurship...
Technology Novel Delivery Platform For Controlled Release Of Bacterial Metabolites To Modulate The Immune System Conditioning of the immune system by the microbiome has received substantial attention for the scientific community in recent years. Microbial metabolites are being assessed as novel therapeutic tools for various…
